With the required aglycon building block in hand, we next turned our attention to the synthesis of 11. As
14
2 2 2 2
depicted in Scheme 3, upon activation by Tf O/Ph SO at –68 °C in CH Cl for 2 h, the D-arabinofuranose
donor 1a was condensed with the phenol derivative 5 to give solely the β-monosaccharide glycoside 6 in 78%
yield. The β-configuration of the newly formed arabinofuranosidic bond was clearly determined by the doublet
11
for the anomeric signal of the Araf unit (δH1 = 5.633 ppm, d, JH1/H2 = 4.8 Hz). Removal of the 5-O-Quin group
of 6 by treatment with sodium methoxide in methanol followed by Swern oxidation of the resulting alcohol
afforded the corresponding aldehyde 7 in 70% yield over the two steps. Then, after reaction with Grignard
reagent methylmagnesium bromide (MeMgBr) in THF at –78 °C and followed by oxidation with the Dess-Martin
reagent, compound 7 was readily converted into methyl ketone 8 (65% yield, two steps from 7). Selective
cleavage of the TBS group of 8 by treatment with tetrabutylammonium fluoride (TBAF) buffered with HOAc in
THF yielded free alcohol 9 in a good 85% yield. Finally, the stage was set to oxide this material to the target
1
5
carboxylic acid product 11. However, subjection of 9 to the well-studied TEMPO oxidation protocol failed to
generate the desired acid 11. Instead, only a trace amount of aldehyde 10 was obtained. Pleasingly, successful
conversion of 9 to 11 was achieved by a two-step procedure. Firstly, the hydroxyl group of 9 was oxided to
aldehyde group by treatment of 9 under Dess-Martin conditions, giving rise to aldehyde 10 in 88% yield.
16
Secondly, oxidation of 10 under Pinnick oxidation conditions (NaClO
expected acid 11 in 75% yield.
2 2 4
, NaH PO ) led to the formation of the
In conclusion, we have developed an efficient approach to the construction of the difficult-to-obtain phenol
1,2-cis furanosyl glycosidic linkages using a HAD strategy. The methodology was applied successfully to the
short synthesis of the sugar fragment of hygromycin A. Further application of the method to the preparation of
carbohydrates bearing an aryl 1,2-cis furanoside structure is currently underway.
Acknowledgements
We appreciate NSFC (21572145, 21372166, 21321061) of China for financial support.
A. Supplementary data
Supplementary data associated with this article can be found, in the online version, at http:// .
References and notes
1.
(a) Pittenger, R. C.; Wolfe, R. N.; Hohen, M. M.; Marks, P. N.; Daily, W. A.; McGuire, M. Antibiot.
Chemother. 1953, 3, 1268; (b) Mann, R. L.; Gale, R. M.; Van Abeele, F. R. Antibiot. Chemother. 1953, 3,
1
279; (c) Sumiki, Y.; Nakamura, G.; Kawasaki, M.; Yamashita, S.; Anzai, K.; Isono, K.; Serizawa, Y.;
Tomiyama, Y.; Suzuki, S. J. Antibiot. 1955, 8, 170; (d) Isono, K.; Yamashita, S.; Tomiyama, Y.; Suzuki, S. J.
Antibiot. 1957, 10, 21; (e) Wakisaka, Y.; Koizumi, K.; Nishimoto, Y.; Kobayashi, M.; Tsuji, N. J. Antibiot.
1
980, 33, 695.
2.
(a) Hecker, S. J.; Minich, M. L.; Werner, K. M. Bioorg. Med. Chem. Lett. 1992, 2, 533; (b) Hecker, S. J.;
Lilley, S. C.; Minich, M. L.; Werner, K. M. Bioorg. Med. Chem. Lett. 1992, 2, 1015; (c) Hecker, S. J.; Lilley,
S. C.; Werner, K. M. Bioorg. Med. Chem. Lett. 1992, 2, 1043; (d) Hecker, S. J.; Cooper, C. B.; Blair, K. T.;
Lilley, S. C.; Minich, M. L.; Werner, K. M. Bioorg. Med. Chem. Lett. 1993, 3, 289; (e) Cooper, C. B.; Blair,
K. T.; Jones, C. S.; Minich, M. L. Bioorg. Med. Chem. Lett. 1997, 7, 1747.
3.
(a) Isono, K. Pharmacol. Ther. 1991, 52, 269; (b) Knapp, S. Chem. Rev. 1995, 95, 1859.
4.
(a) Kirst, H. A.; Dorman, D. E.; Occolowitz, J. L.; Jones, N. D.; Paschal, J. W.; Hamill, R. L.; Szymanski, E.
F. J. Antibiot. 1985, 38, 575; (b) Barrasa, M. I.; Tercero, J. A.; Lacalle, R. A.; Jimenez, A. Eur. J. Biochem.
6